Clarity Pharmaceuticals Ltd
ASX:CU6
Prices of ASX stocks are not being updated. The latest CU6 price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
|
F
|
First Solar Inc
F:F3A
|
US |
|
T
|
TD Synnex Corp
F:SUX
|
US |
|
Trutankless Inc
OTC:TKLS
|
US |
|
Saga Pure ASA
F:SAT
|
NO |
|
Holding Company ADMIE IPTO SA
F:08M
|
GR |
|
T
|
Tabcorp Holdings Ltd
XMUN:THL
|
AU |
Intrinsic Value
Is CU6 undervalued or overvalued?
See the intrinsic value estimate for Clarity Pharmaceuticals Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CU6 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CU6’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Clarity Pharmaceuticals Does
Clarity Pharmaceuticals is a radiopharmaceutical company that develops drugs used in medical imaging and cancer treatment. Its main idea is to attach copper-based radioactive isotopes to targeting molecules so doctors can see tumors more clearly on scans or deliver radiation directly to cancer cells.
- Headquarters
- Australia AU
- IPO date
- Aug 25, 2021
Earnings Waterfall
Clarity Pharmaceuticals Ltd
The intrinsic value for Clarity Pharmaceuticals Ltd (CU6) under the Base Case is hidden AUD.
Compared with the last price of 1.825 AUD on Oct 14, the stock appears hidden.